However, fourth quarter revenue dropped by nearly 3 percent from approximately $1.12 billion in 2011 to $1.1 billion in 2012. Year end attributable profit rose nearly 25 percent from $582 million to $729 million.
Smith & Nephew’s revenue for surgical devices decreased by nearly 5 percent in the fourth quarter, with $797 million in 2012 compared to $835 million in 2011. Overall 2012 revenue for surgical devices also dropped 4 percent. Fourth quarter advanced wound management revenue increased by 3 percent, from $271 million to $280.
More Articles on Devices:
Stanmore Receives FDA Approval for Robotic Partial Knee Surgery
Zimmer Must Pay Stryker $70M for Patent Infringement
Victrex Looks for Market Growth in 2013
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.